Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Tatva Chintan Pharma Chem Ltd

TATVA.NS ✓ COMPLIANT ☆ Track — members

NSE India · Basic Materials · Specialty Chemicals ·

India Small Cap Analyst: HOLD

Last Close

$17.99

▲ +0.45%

Market Cap $420.91M · Vol 34.28K

Key Metrics

P/E Ratio

78.16

FWD: 52.61

Market Cap

$420.91M

Small Cap

Div Yield

0.06%

Annual dividend

EPS Growth

+58.55%

YoY

RSI (14)

42.05

Momentum

Beta

1.38

vs Market

52W High

$19.26

6.68% below

52W Low

$10.23

62.60% above

Volume

34.28K

Avg 263.06K

P/B

3.15

Price-to-book

ROE

5.53%

Return on equity

Free Float

25.84%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Tatva Chintan Pharma Chem Ltd (TATVA.NS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does TATVA.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-0.09%

+21.61%

+36.00%

+43.44%

YTD

+28.71%

+64.37%

-13.80%

-20.44%

Financials & Valuation

TTM · Annual

Total Revenue	$54.13M
Net Income	$4.50M
Revenue Growth (YoY)	+42.95%
Gross Margin	48.33%
Operating Margin	11.13%
Net Profit Margin	8.31%
ROE	5.53%
ROA · ROIC	6.20% · 5.27%

P/E Ratio	78.16
Forward P/E (FY1)	52.61
PEG Ratio	0.09
P/S	4.87
P/B	3.15
P/FCF	N/A
EPS Growth	+58.55%
Outstanding Shares	23.39M

Technical Indicators

50-Day SMA	$15.02
200-Day SMA	$13.88
RSI (14)	42.05
Beta	1.38
52-Week High	$19.26
52-Week Low	$10.23

Volume Today	34.28K
Avg Daily Volume (30D)	263.06K
Relative Volume	0.13x
Volatility (10D)	26.96
Volatility (30D)	68.57
Free Float	25.84%

Analyst Consensus

HOLD

Current Price $17.99

Mean Target $14.96

52W Low$10.23 52W High$19.26

Current

Target

$10.23 $19.26

Current Analyst target

-16.87% downside risk · 4 analysts

Identifiers

ExchangeNSE India

FIGIBBG00KK4D7B2

ISININE0GK401011

CountryIndia

Sub-IndustrySpecialty Chemicals (NEC)

Earnings DateOct 30, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

ECL Ecolab Inc -0.05% SIKA.S Sika AG -0.16% GIVN.S Givaudan SA +0.31% 4901.T Fujifilm Holdings Corp +1.59% EMSN.S Ems Chemie Holding AG +0.57%

Company Profile

Tatva Chintan Pharma Chem Limited is an India-based specialty chemical manufacturing company. The Company is primarily engaged in manufacturing, sale and distribution of specialty chemicals, phase transfer catalysts (PTC), structure directing agents (SDA), electrolyte salts and solutions (ESS), pharmaceutical and agrochemical intermediates and other specialty chemicals (PASC). It operates in the Specialty chemical segment. Its SDA is a high purity quaternary salt, which plays a role in forming channels during the synthesis of zeolites. PTC acts as a catalyst in chemical reactions, facilitating reactions between reactants of different phases. Its products serve various sectors, including automotive, refinery, pharmaceutical, agrochemicals, paints and coatings, dyes and pigments, personal care, and flavors and fragrances. The Company operates two manufacturing facilities situated at Ankleshwar and Dahej in Bharuch, Gujarat, India.